AzPA Health System Special Interest Group (Az-ASHP)
Spring Clinical Meeting - March 4th and 5th
AzPA’s Spring Clinical Conference serves as our ASHP state a liate chapter’s annual meeting, and we are excited to be o ering many topics of interest to health systems pharmacists. The content has been designed to engage practitioners of all experience levels. We hope to see you there!
74th Sessions of ASHP's House of Delegates
Please join our delegates for a town hall at the upcoming Spring Clinical Conference! This is your opportunity to weigh in on draft ASHP policy language so that your delegates can better represent you as a member of the Arizona Health Systems Pharmacy community
This year, the 74th House of Delegates reviewed and ultimately approved an unprecedented 44 policies and 6 statements that will help shape ASHP’s approach to issues facing our profession Danielle Kamm, Melinda Burnworth, and I are proud to serve as delegates and assist with this important work We are aided by an impressive roster of alternate delegates, including: Christi Jen, Carol Rollins, Janelle Duran, and Jacob Schwarz.
ASHP Leadership
Congratulations to our very own Dr. Christi Jen on her election to the position of Chair for ASHP’s Section of Clinical Specialists and Scientists. Dr. Jen has dedicated countless hours of service to AzPA and ASHP in the interest of advancing pharmacy practice and bettering patient care. Her leadership in both organizations is truly inspiring. Congratulations Christi and thank you for all that you do!
Az-ASHP Participation - We Want You!
The SIG is actively recruiting new members. If you are interested in getting involved, please sign up using the link below. We meet monthly to discuss issues relevant to health systems pharmacists in Arizona I look forward to seeing you on our next Health System Special Interest Group call!
All the best,
Sign-Up HERE
Christopher J. Edwards, PharmD, BCPS, FASHP,FAzPA AzPA Board of Directors-Health System
8:15AM - 9:15AM / Let Your Voice Be Heard: A Discussion of Advocacy and ASHP House of Delegates
Christopher Edwards, PharmD, BCPS, FASHP, FAzPA; Mindy Burnworth, PharmD, BCPS, FASHP, FAzPA; Janelle Duran, PharmD, BCPS
Pharmacist Learning Objectives:
1. Describe ways Arizona pharmacy professionals can get involved in advocacy through state and national pharmacy associations
2 Discuss the role of Arizona delegates to the ASHP House of Delegates
3 Discuss the potential impact of selected policies coming before the ASHP House of Delegates in June to the practice of pharmacy in Arizona and to pharmacy personnel
Technician Learning Objectives:
1 Describe how a pharmacy technician may contribute to ASHP policies
2 Understand how policies may impact pharmacy technicians
9:15AM - 10:15AM / ASHP: A National Perspective on Current Pharmacy Issues
David Warner, PharmD-Senior Director, Consulting and Practice Development-ASHP
10:45AM - 11:45AM / Focus on Sepsis: Medication Review
Kathleen Bloomquist, PharmD; Brian Kopp, PharmD, BCPS, FCCM
Pharmacist Learning Objectives:
1 Describe the pathophysiologic basis for hemodynamic instability in septic shock
2. Identify vasopressors that are likely to be of bene t in patients experiencing septic shock
3 Identify uids used in resuscitation that are most likely to remain in the intravascular space
Technician Learning Objectives:
1 Identify vasopressors that are likely to be of bene t in patients experiencing septic shock
2 Identify uids used in resuscitation that are most likely to remain in the intravascular space
10:45AM - 11:45AM / Focus on Hyperlipidemia: Medication Review
Lauren Rimsza, PharmD; Amy Kennedy, PharmD, BCACP; Alejandro Vazquez, PharmD
Pharmacist Learning Objectives:
1 Describe the mechanisms of action (MOA) of evinacumab and bempedoic acid
2 List the adverse e ect pro les of evinacumab and bempedoic acid
3 Recall the data that demonstrates the e cacy of evinacumab and bempedoic acid
Technician Learning Objectives:
1 List the new treatment options that are alternatives to statin therapy
2 Discuss the storage requirements, dosage forms, and strengths available for these alternative treatment options
1:00PM - 2:00PM / Focus on Sepsis: Guideline Update Gabriella Gambadoro, PharmD; Brian Kopp, PharmD, BCPS, FCCM
Pharmacist Learning Objectives:
1 Summarize the role of corticosteroids in managing sepsis
2 Review the goal timing of antibiotics when treating patients with sepsis
3 Di erentiate patients with sepsis who may bene t from a uid restricted resuscitation strategy
Technician Learning Objectives:
1 Summarize the role of corticosteroids in managing sepsis
2. Review the goal timing of antibiotics when treating patients with sepsis
1:00PM - 2:00PM / Focus on Hyperlipidemia: Guideline Update Caroline Adrian, PharmD; Jacob Northrup, PharmD, BC-ADM, CDCES
Pharmacist Learning Objectives:
1 Summarize most recent updates to guideline(s)
2 Review lipid goals and ASCVD risk factors and identify indications for treatment
3 Contrast treatment options for hyperlipidemia based on most recent guideline(s)
Technician Learning Objectives:
1 Summarize most recent updates to guideline(s)
2 List the rst line medications recommended by the guideline(s) for the treatment of hyperlipidemia
2:00PM - 3:00PM / Focus on Sepsis: Patient Case for the New Practitioner Jacob Schwarz, PharmD, MBA, BCIDP, BCCCP, BCPS, FAzPA
Pharmacist Learning Objectives:
1. Apply criteria for sepsis and/or septic shock to a patient case
2 Design an appropriate resuscitation strategy for a hemodynamically unstable patient with septic shock
3 Apply criteria for initiating corticosteroid treatment to a patient case
2:00PM - 3:00PM / Focus on Hyperlipidemia: Patient CaseWhen Statins Aren't Enough
Erin Raney, PharmD, BCPS, BC-ADM
Pharmacist Learning Objectives:
1 Choose treatment goals for hyperlipidemia based on patient speci c characteristics
2 Recommend treatment for hyperlipidemia based on patient speci c characteristics
3. Monitor treatment outcomes for hyperlipidemia based on patient speci c characteristics
2:00PM - 3:00PM / Focus on Sepsis: Medication Safety and the Technician's Role
Christi Jen, PharmD, BCPS, FASHP, FAzPA; Sylvia Gomez, CPhT
Technician Learning Objectives:
1 Describe the consequences of delays in antibiotics when treating patients with sepsis
2 List 4 medications that are truly STAT when treating patients with septic shock
3:15PM - 4:15PM / Focus on Sepsis: Therapeutic Debate
Christopher Edwards, PharmD, BCPS, FASHP; Brian Kopp, PharmD, BCPS, FCCM
Pharmacist Learning Objectives:
1. Critique the evidence for and against a liberal uid resuscitation in early management of sepsis
2 Evaluate the evidence for “maximum” doses of norepinephrine when treating patients with septic shock
3 Evaluate the literature for the use of balanced salt solutions or saline as resuscitative uids in patients with sepsis and septic shock
3:15PM - 4:15PM / Focus on Hyperlipidemia: Therapeutic Debate-How Old Is Too Old? Debating the Use of Statins for Primary Prevention in the Elderly
Ariane Guthrie, PharmD, BCPS; Thu Nguyen, PharmD, BCGP, BCPS
Pharmacist Learning Objectives:
1 Evaluate the evidence for initiating statin therapy for primary prevention in older adults
2 Evaluate the evidence for deprescribing statins in persons with advanced age
3 Compare risks and bene ts of statins for primary prevention in older adults
4:30PM - 5:30PM / Demystifying Pain ManagementOverview of the 2022 CDC Opioid Guidelines Update
Christopher Edwards, PharmD, BCPS, FASHP; Amy Kennedy, PharmD, BCACP
Learning Objectives:
1 Given a patient case, develop a plan to taper the patient o of long-term opioid therapy
2 Evaluate a patient case to determine if co-prescribing of naloxone is appropriate
3 Di erentiate between substances detectable and not detectable on commonly available opioid screening assays
8:15AM - 9:30AM / Pharmacy Law Update
Roger Morris, RPh, JD; Katie Lavigne, JD; Kaitlyn Fydenkevez, JD
Learning Objectives:
1. Describe rami cations of recent pharmacy-related court cases
2 List recent changes in Federal Pharmacy Law
3 List recent changes in State Pharmacy Law
9:45AM - 10:45AM / Interstitial Lung Disease Associated with Anticancer Therapy
Farah Raheem, PharmD, BCOP
Pharmacist Learning Objectives:
1 Identify anticancer agents associated with pulmonary toxicity
2 Describe diagnosis of treatment related interstitial lung disease
3 De ne grading of anticancer treatment-related interstitial lung disease
4 Discuss management of anticancer treatment related interstitial lung disease and pneumonitis
9:45AM - 10:45AM / Immunization Update - Jeopardy Style!
Holly Van Lew, PharmD, BCPS, AAHIVP
Pharmacist Learning Objectives:
1 Discuss the most recent updates for routine vaccinations, including pneumococcal, Hepatitis B and other vaccines with updated indications and expanded age ranges
2 Apply the current recommendations for COVID-19 vaccinations to case-based scenarios and review planned commercialization activities for COVID-19 vaccinations
3 Assess current immunization practices at your practice site and determine implementation strategies for expanding vaccination e orts
4 Discuss vaccine administration best practices, including injection technique and documentation
Technician Learning Objectives:
1 Describe tools and resources available for immunization schedules and recommendations
2. Identify the appropriate age-based recommendations for immunizations that impact dose and route of administration
3 Determine ways to support increased vaccine administration and improve work ow to support vaccinations
4. Discuss vaccine administration best practices, including injection technique and documentation
9:45AM - 10:45AM / Pharmacogenomics Primer for Pharmacists
Adrijana Kekic, PharmD, BCACP
Pharmacist Learning Objectives:
1. Discuss navigation of genotype-based guidelines
2 Discuss the current and future role of the pharmacist in pharmacogenomics (PGx) implementation e orts
3 De ne the role of pharmacogenomics in personalized drug therapy
4 Identify pharmacogenomics resources
10:45AM - 12:15PM / Advances in Pharmacotherapy
Robert Lipsy, PharmD, BCACP, FASHP, FAzPA
Pharmacist Learning Objectives:
1 Identify new drugs approved in 2022-2023
2 Describe the anticipated bene ts of the newly approved drugs
3 Describe the possible adverse drug reactions of the newly approved drugs
4 Summarize any speci c storage or administration of the newly approved drugs
Technician Learning Objectives:
1 Identify new drugs approved in 2022-2023
2 Identify drug related questions that require the technician to refer to the pharmacist
3 Summarize any speci c storage recommendation of the newly approved drugs
10:45AM - 11:45AM / Health Needs of Refugees in Arizona: Caring for Traumatized People ... And For Yourself
Kathleen Fairman, MA, PhD; Mary Kaech; Juliana Davis
Learning Objectives:
1. Explain principles of trauma-informed care for vulnerable refugee populations
2 Explain self-care strategies to protect against negative health consequences of refugee work among health care workers
3 Describe the demographic pro le of Arizona's refugees
4 Describe the health pro le of refugee populations
EARLY BIRD REGISTRATION OPEN UNTIL FEBRUARY 14, 2023!
REGISTER HERE
Location: Creighton University - School of Pharmacy and Health Sciences
3100 N Central Ave, Phoenix, AZ 85012
